Corrected on Mar 5, 2020.
Source: the publisher, via Crossref · checked Oct 29, 2026 · Read the notice
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan, Kin-Hang Kok, Zheng Zhu and 4 more
Emerging Microbes & Infections · 2020
doi:10.1080/22221751.2020.1719902
Abstract
A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization. We performed bioinformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes. Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike’s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection.
Cited by papers we hold 71
- Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines · 2022No notice
- Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection · 2021Not checked
- The Mechanisms and Animal Models of SARS-CoV-2 Infection · 2021Not checked
- SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns · 2021No notice
- De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning · 2021Not checked
- Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro · 2021No notice
- Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 · 2021No notice
- SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response · 2021No notice
- Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection · 2021No notice
- The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes · 2021No notice
- The coronavirus proofreading exoribonuclease mediates extensive viral recombination · 2021No notice
- Host and viral determinants for efficient SARS-CoV-2 infection of the human lung · 2021No notice
- The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι · 2021No notice
- SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes · 2021No notice
- Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation · 2021No notice
- Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies · 2021No notice
- Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase · 2021No notice
- Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic · 2021No notice
- The glycosylation in SARS-CoV-2 and its receptor ACE2 · 2021No notice
- Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study · 2020No notice
and 51 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.